Stanley Leon Hazen MD

Summary

• Dr. Hazen, based in Cleveland Ohio, is an elected fellow to the National Academy of Medicine, USA. He also is an elected fellow of the American Association for the Advancement of Science, and an elected member of the American Association of Physicians.
  
  Dr. Hazen ranks among the top 0.05% most cited investigators worldwide (H-index 163; citations >175,000) and has published >500 articles in basic and clinical journals alike in the fields of cardiovascular disease (CVD), lipid metabolism and inflammation. He has made pioneering discoveries in mechanisms contributing to cardiovascular and inflammatory diseases, including fundamental studies linking defined oxidation pathways to CVD risk, diagnostics and therapeutics. He made the seminal discovery linking gut microbial pathways to CVD pathogenesis; and in recent studies identified sugar alcohols as clinical and mechanistic contributors to heightened thrombosis and adverse CVD events. His research in multiple areas has impacted clinical practice, and lays the foundation for both FDA- and EU-cleared diagnostic tests for CVD risk assessment in use worldwide. His research has also helped to spawn pharmaceutical development of CVD drugs in clinical trials.